Emmaus Life Sciences Stock Operating Margin
| EMMADelisted Stock | USD 0.13 0.00 0.00% |
Emmaus Life Sciences fundamentals help investors to digest information that contributes to Emmaus Life's financial success or failures. It also enables traders to predict the movement of Emmaus OTC Stock. The fundamental analysis module provides a way to measure Emmaus Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emmaus Life otc stock.
Emmaus |
Emmaus Life Sciences OTC Stock Operating Margin Analysis
Emmaus Life's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Emmaus Life Operating Margin | (0.65) % |
Most of Emmaus Life's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emmaus Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Emmaus Life Sciences has an Operating Margin of -0.6546%. This is 98.13% lower than that of the Pharmaceuticals sector and 99.42% lower than that of the Health Care industry. The operating margin for all United States stocks is 88.12% lower than that of the firm.
Emmaus Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emmaus Life's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emmaus Life could also be used in its relative valuation, which is a method of valuing Emmaus Life by comparing valuation metrics of similar companies.Emmaus Life is currently under evaluation in operating margin category among related companies.
Emmaus Fundamentals
| Return On Asset | -0.12 | ||||
| Profit Margin | (1.14) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 49.41 M | ||||
| Shares Outstanding | 49.56 M | ||||
| Shares Owned By Insiders | 38.73 % | ||||
| Number Of Shares Shorted | 41.22 K | ||||
| Price To Earning | (1.60) X | ||||
| Price To Sales | 1.06 X | ||||
| Revenue | 20.61 M | ||||
| Gross Profit | 17.3 M | ||||
| EBITDA | (12.76 M) | ||||
| Net Income | (15.95 M) | ||||
| Cash And Equivalents | 982 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 4.65 M | ||||
| Debt To Equity | (0.04) % | ||||
| Current Ratio | 0.14 X | ||||
| Book Value Per Share | (0.76) X | ||||
| Cash Flow From Operations | (1.25 M) | ||||
| Short Ratio | 0.48 X | ||||
| Earnings Per Share | (0.18) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 58 | ||||
| Beta | 1.97 | ||||
| Market Capitalization | 24.28 M | ||||
| Total Asset | 56.73 M | ||||
| Retained Earnings | (82.78 M) | ||||
| Working Capital | 1.95 M | ||||
| Current Asset | 9.19 M | ||||
| Current Liabilities | 7.25 M | ||||
| Z Score | 1.6 | ||||
| Net Asset | 56.73 M |
About Emmaus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Emmaus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emmaus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emmaus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emmaus Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emmaus Life's short interest history, or implied volatility extrapolated from Emmaus Life options trading.
Pair Trading with Emmaus Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emmaus Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Emmaus OTC Stock
| 0.61 | ELOX | Eloxx Pharmaceuticals | PairCorr |
Moving against Emmaus OTC Stock
| 0.53 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.51 | ENGN | enGene Holdings Common | PairCorr |
| 0.51 | BAYRY | Bayer AG PK | PairCorr |
| 0.5 | NGM | NGM Biopharmaceuticals Earnings Call This Week | PairCorr |
| 0.5 | NRSNW | NeuroSense Therapeutics | PairCorr |
The ability to find closely correlated positions to Emmaus Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emmaus Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emmaus Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emmaus Life Sciences to buy it.
The correlation of Emmaus Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emmaus Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emmaus Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emmaus Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |